These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35192363)

  • 1. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L.
    Prigaro BJ; Esquer H; Zhou Q; Pike LA; Awolade P; Lai XH; Abraham AD; Abbott JM; Matter B; Kompella UB; Messersmith WA; Gustafson DL; LaBarbera DV
    J Med Chem; 2022 Mar; 65(5):3943-3961. PubMed ID: 35192363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer.
    Clune S; Awolade P; Zhou Q; Esquer H; Matter B; Kearns JT; Kellett T; Akintayo DC; Kompella UB; LaBarbera DV
    Biomed Pharmacother; 2024 Jan; 170():116037. PubMed ID: 38128184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.
    Abbott JM; Zhou Q; Esquer H; Pike L; Broneske TP; Rinaldetti S; Abraham AD; Ramirez DA; Lunghofer PJ; Pitts TM; Regan DP; Tan AC; Gustafson DL; Messersmith WA; LaBarbera DV
    Mol Cancer Ther; 2020 Aug; 19(8):1598-1612. PubMed ID: 32499299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.
    Fan GT; Ling ZH; He ZW; Wu SJ; Zhou GX
    Biochem Biophys Res Commun; 2021 May; 554():214-221. PubMed ID: 33813077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
    Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
    J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
    Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
    PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD1L: a novel oncogene.
    Cheng W; Su Y; Xu F
    Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
    Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
    J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
    Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
    Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
    Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
    Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chromodomain helicase/ATPase DNA binding protein 1-like gene on the invasion and metastasis of tongue squamous cell carcinoma CAL27 cells.
    Hu KL; Fan X; Hu WT; Li HL; Tang QH; Sun XH
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):81-87. PubMed ID: 33723941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2.
    He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF
    Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
    Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
    Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells.
    Xu X; He Y; Miao X; Wu Y; Han J; Wang Q; Liu J; Zhong F; Ou Y; Wang Y; He S
    Leuk Res; 2016 Aug; 47():54-62. PubMed ID: 27258734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
    Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
    Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
    Liu W; Xu J; Zhang C
    Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
    Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
    Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
    Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromodomain Helicase DNA Binding Protein 1-like, a negative regulator of Forkhead box O3a, promotes the proliferation and migration of Angiotensin II-induced vascular smooth muscle cells.
    Zhang X; Sun Y
    Bioengineered; 2022 Feb; 13(2):2597-2609. PubMed ID: 35001835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.